| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.3 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.3 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |